BIOCRYST PHARMACEUTICALS INC Insider Trading for June 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOCRYST PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOCRYST PHARMACEUTICALS INC for June 2015.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 4.73 | 3,750 | 17,738 | 11,750 | |
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 16.00 | 3,750 | 60,000 | 146,144 | 149.9 K to 146.1 K (-2.50 %) |
Jun 24 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 4.73 | 3,750 | 17,738 | 149,894 | 146.1 K to 149.9 K (+2.57 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Sell | S | 15.00 | 3,000 | 45,000 | 68,876 | 71.9 K to 68.9 K (-4.17 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | M | 2.58 | 70,389 | 181,604 | 42,112 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Sell | S | 15.05 | 70,389 | 1,059,354 | 95,123 | 165.5 K to 95.1 K (-42.53 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Buy | M | 1.20 | 70,389 | 84,467 | 165,512 | 95.1 K to 165.5 K (+74.00 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,175 | 12,002 | 101,760 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,100 | 11,718 | 104,935 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | M | 3.78 | 3,100 | 11,718 | 108,035 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 15.00 | 3,175 | 47,625 | 146,144 | 149.3 K to 146.1 K (-2.13 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,175 | 12,002 | 149,319 | 146.1 K to 149.3 K (+2.17 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 15.00 | 3,500 | 52,500 | 146,144 | 149.6 K to 146.1 K (-2.34 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 13.50 | 3,100 | 41,850 | 149,644 | 152.7 K to 149.6 K (-2.03 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 14.25 | 3,100 | 44,175 | 152,744 | 155.8 K to 152.7 K (-1.99 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,100 | 11,718 | 155,844 | 152.7 K to 155.8 K (+2.03 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Buy | M | 3.78 | 3,100 | 11,718 | 152,744 | 149.6 K to 152.7 K (+2.07 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 14.00 | 3,500 | 49,000 | 149,644 | 153.1 K to 149.6 K (-2.29 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | M | 1.20 | 20,000 | 24,000 | 80,000 | |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Sell | S | 15.02 | 20,000 | 300,400 | 650,869 | 670.9 K to 650.9 K (-2.98 %) |
Jun 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Buy | M | 1.20 | 20,000 | 24,000 | 670,869 | 650.9 K to 670.9 K (+3.07 %) |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Barnes Alane P | VP, General Counsel ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Babu Yarlagadda S | Senior VP - Drug Di ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Sheridan William P | Senior VP - CMO | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Option Exercise | A | 5.45 | 17,000 | 92,650 | 17,000 | |
Jun 16 2015 | BCRX | BIOCRYST PHARMACEU ... | Stonehouse Jon P | President & CEO | Option Exercise | A | 5.45 | 25,000 | 136,250 | 25,000 | |
Jun 09 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 12.75 | 6,000 | 76,500 | 153,144 | 159.1 K to 153.1 K (-3.77 %) |
Jun 02 2015 | BCRX | BIOCRYST PHARMACEU ... | STAAB THOMAS R II | Senior Vice Preside ... | Sell | S | 12.00 | 3,000 | 36,000 | 159,144 | 162.1 K to 159.1 K (-1.85 %) |
Jun 01 2015 | BCRX | BIOCRYST PHARMACEU ... | Cohen Fred E | Director | Grant | A | 11.21 | 780 | 8,744 | 103,094 | 102.3 K to 103.1 K (+0.76 %) |